126 related articles for article (PubMed ID: 3926447)
1. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Heidrich H
Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
[No Abstract] [Full Text] [Related]
2. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
Brüning G
Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
[No Abstract] [Full Text] [Related]
3. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
4. [Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
Wampola H
Fortschr Med; 1977 May; 95(18):1240,1242-5. PubMed ID: 405291
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral blood flow velocity in arterial occlusive disease during i.v. long term therapy with vasoactive agents. Plethysmographic comparative study].
Heidrich H; Witt D; Witt E
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1750-2. PubMed ID: 347800
[No Abstract] [Full Text] [Related]
6. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
7. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
Schuster CJ; von Ungern-Sternberg AF
ZFA (Stuttgart); 1976 Jan; 52(2):105-10. PubMed ID: 817527
[No Abstract] [Full Text] [Related]
8. [Buflomedil in arterial occlusive disease. Results of a controlled study].
Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
[No Abstract] [Full Text] [Related]
9. [Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination].
Lesch OM; Musalek M; Dietzel M; Grünberger J; Saletu B; Schjerve M; Walter H; Werner U; Zeiler K
Wien Med Wochenschr; 1985 Sep; 135(18):459-65. PubMed ID: 3933188
[TBL] [Abstract][Full Text] [Related]
10. [Training by walking and drug therapy of peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
[No Abstract] [Full Text] [Related]
11. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
De Gregorio G; Restivo S
Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
[No Abstract] [Full Text] [Related]
12. [Current EMNID survey on peripheral arterial occlusive disease].
Krankenpfl J; 2002; 40(7-9):217. PubMed ID: 12514861
[No Abstract] [Full Text] [Related]
13. Pharmacologic therapy for intermittent claudication.
Dobesh PP; Stacy ZA; Persson EL
Pharmacotherapy; 2009 May; 29(5):526-53. PubMed ID: 19397462
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
15. [Conservative treatment of peripheral arterial occlusive diseases].
Hoffmann J
Fortschr Med; 1978 Sep; 96(34):1735-8. PubMed ID: 101431
[TBL] [Abstract][Full Text] [Related]
16. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
Spitzer S; Bach R; Schieffer H
Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
Ambrosi V; Gabrielli F
Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
Becker HM; Elert O; Häring R; Maurer PC; Raithel D; Sperling M; Stockmann U; Storz LW; Hirche H
Med Welt; 1979 Oct; 30(43):1602-6. PubMed ID: 514039
[No Abstract] [Full Text] [Related]
19. Oral vasoactive medication in intermittent claudication: utile or futile?
De Backer TL; Vander Stichele RH; Warie HH; Bogaert MG
Eur J Clin Pharmacol; 2000 Jun; 56(3):199-206. PubMed ID: 10952473
[TBL] [Abstract][Full Text] [Related]
20. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
Lepäntalo M; Sundberg S; Gordin A
Scand J Rehabil Med; 1984; 16(4):159-62. PubMed ID: 6397852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
